Clinical Trial Update: Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating extracorporeal photopheresis with 5-aminolevulinic acid for Crohn's disease has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• extracorporeal photopheresis with 5-aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: COMPLETED